Document Detail

Transplantation tolerance by a combined therapy with sulfatide, anti-LFA-1/ICAM-1 monoclonal antibodies and FK506 in rat cardiac transplantation.
MedLine Citation:
PMID:  9665003     Owner:  NLM     Status:  MEDLINE    
Selectins promote a rolling phenomenon of leukocytes along activated endothelial surfaces, which is the first step in the events that ultimately lead to leukocyte transmigration at acute inflammatory sites. Our previous study revealed that sulfatide, which is one of the selectin inhibitors, prolonged graft survival in rat cardiac allografts. In the present study, to obtain a longer graft acceptance, we examined a combination treatment of sulfatide, monoclonal antibodies (mAbs) against LFA-1/ICAM-1, and FK506 in a Fischer 344 (F344, RT1lvl) to Lewis (LEW, RT1l) rat heart transplantation. FK506 alone (n = 6) and FK506/sulfatide-treated LEW rats (n = 6) rejected F344 heart grafts with an MST of 49 and 55.2 days, respectively. Otherwise, four out of six heart grafts treated with sulfatide, mAbs against LFA-1/ICAM-1, and FK506 (n = 6) survived for over 100 days after transplantation. The proliferative response of alloreactive T cells obtained from tolerant rats against both F344 alloantigen and third-party alloantigen on day 104 postgrafting was significantly suppressed as compared to that from naive LEW rats. On light microscopic examination, specimens of tolerant rat on day 104 postgrafting showed an almost normal appearance. Our results suggested that blocking both each step of leukocyte entry and recognition of alloantigens by a combination treatment of sulfatide, mAbs against LFA-1/ICAM-1, and FK506 could lead to tolerance.
H Horimoto; T Ito; T Hayashi; M Miyasaka; M Nozawa
Related Documents :
3325513 - Cyclosporine-induced long-term allograft survival and its potential in posttrauma tissu...
21949663 - The regenerating gene iα is overexpressed in atrophic gastritis rats with hypergastrine...
8075213 - Isolation of strongyloides venezuelensis from rattus norvegicus in kagoshima prefecture.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplant international : official journal of the European Society for Organ Transplantation     Volume:  11 Suppl 1     ISSN:  0934-0874     ISO Abbreviation:  Transpl. Int.     Publication Date:  1998  
Date Detail:
Created Date:  1998-11-30     Completed Date:  1998-11-30     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  8908516     Medline TA:  Transpl Int     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  S310-2     Citation Subset:  IM    
Department of Surgery, Meikai University, Saitama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal / therapeutic use*
Drug Therapy, Combination
Graft Survival
Heart Transplantation / immunology*
Immune Tolerance*
Immunosuppressive Agents / therapeutic use*
Intercellular Adhesion Molecule-1 / immunology*
Lymphocyte Function-Associated Antigen-1 / immunology*
Rats, Inbred F344
Rats, Inbred Lew
Sulfoglycosphingolipids / therapeutic use*
Tacrolimus / therapeutic use*
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunosuppressive Agents; 0/Lymphocyte Function-Associated Antigen-1; 0/Sulfoglycosphingolipids; 109581-93-3/Tacrolimus; 126547-89-5/Intercellular Adhesion Molecule-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long-term ca...
Next Document:  Early use of tacrolimus as rescue therapy for refractory liver allograft rejection.